For the Inventor, By the Inventor

Enter inventor name

San Francisco, CA, United States of America

Varghese John

USPTO Granted Patents = 89 (Patent Applications = 24)

CIPO Patents = 5 (Patent Applications = 20)

EPO Patents = 10 (Patent Applications = 28)

Average Co-Inventor Count = 4.7

ph-index = 11

Forward Citations = 397(Granted Patents)

Forward Citations (Not Self Cited) = 367(Dec 10, 2025)

Inventors with similar research interests:

Location History:

South San Francisco, CA (US) (1996)
Los Angeles, CA (US) (2019 - 2022)
Culver City, CA (US) (2021 - 2022)
San Francisco, CA (US) (1996 - 2024)

Company Filing History:

Elan Pharmaceuticals, Inc.

Buck Institute for Research on Aging

9 out of 15,475

University of California

4. 7 out of 523

Pharmacia & Upjohn Company

5. 7 out of 4,446

Eli Lilly and Company

Athena Neurosciences, Inc.

Elan Corporation, Plc

Pharmacia & Upjohn

Elan Oharmaceuticals, Inc.

11. 19 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Alzheimer's Disease

Beta-Secretase Enzyme

Cognitive Impairment

Hydantoins

APP Processing

Triazolopyridines

Muscle Mass Enhancement

Drug Delivery Vehicles

Netrin Loop Peptide

Small Molecules

Cartilage Rejuvenation

Dipeptide Inhibitors

89 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441716 - Compositions and methods for increasing muscle mass and oxidative metabolism (2025-10-14),

2. 12364661 - Deformable nano-scale vehicles (DNVS) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery (2025-07-22),

3. 12157740 - Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau (2024-12-03),

4. RE49873 - APP specific bace inhibitors (ASBIs) and uses thereof (2024-03-19),

5. 11370793 - Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau (2022-06-28),

6. 11325904 - Tropinol esters and related compounds to promote normal processing of APP (2022-05-10),

7. 11247974 - Small molecules that enable cartilage rejuvenation (2022-02-15),

8. 11243215 - 3D-exoquant method for the analysis of surface molecules and quantification of tissue-specific exosomes in biological fluids (2022-02-08),

9. 11142505 - Compositions for APP-selective BACE inhibition and uses therefor (2021-10-12),

10. 11091444 - Hydantoins that modulate BACE-mediated app processing (2021-08-17),

11. 11077108 - Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition (2021-08-03),

12. 11072592 - Small molecules that enable cartilage rejuvenation (2021-07-27),

13. 10947207 - GP130 modulators (2021-03-16),

14. 10844071 - Substituted [1,2,3]triazolo[4,5-d]pyrimidines that lower stress-induced p-tau (2020-11-24),

15. 10835546 - App specific BACE inhibitors (ASBIs) and uses thereof (2020-11-17),

Title: Inventor Varghese John: Pioneering Innovations in San Francisco

Introduction: Varghese John is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Varghese John holds several recent patents in the areas of renewable energy technologies, artificial intelligence systems, and sustainable urban development solutions.

Career Highlights: With a career spanning over two decades, Varghese John has established himself as a leading figure in the innovation landscape, with a track record of transforming bold ideas into tangible realities.

Collaborations: Throughout his career, Varghese John has collaborated with top research institutions, leading companies, and visionary entrepreneurs to bring cutting-edge technologies to the market, fostering a culture of innovation and progress.

Conclusion: Varghese John's relentless pursuit of innovation and his passion for creating a positive impact on society continue to inspire the next generation of inventors and entrepreneurs worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…